StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
908
This year
301
Publishing Date
2023 - 09 - 25
4
2023 - 09 - 18
5
2023 - 07 - 27
6
2023 - 07 - 26
6
2023 - 05 - 19
6
2023 - 05 - 15
6
2023 - 04 - 13
5
2023 - 04 - 12
6
2023 - 04 - 11
5
2023 - 02 - 13
5
2023 - 01 - 24
5
2022 - 12 - 06
4
2022 - 11 - 23
4
2022 - 10 - 20
4
2022 - 09 - 29
4
2022 - 09 - 26
4
2022 - 09 - 19
5
2022 - 08 - 17
4
2022 - 08 - 02
4
2022 - 06 - 17
5
2022 - 05 - 16
4
2022 - 04 - 28
7
2022 - 04 - 13
5
2022 - 04 - 12
4
2022 - 04 - 08
4
2022 - 03 - 16
4
2022 - 03 - 10
4
2022 - 03 - 08
4
2022 - 03 - 01
5
2022 - 02 - 18
3
2022 - 02 - 17
4
2022 - 01 - 05
3
2021 - 12 - 14
4
2021 - 12 - 13
3
2021 - 12 - 06
3
2021 - 11 - 15
3
2021 - 11 - 04
4
2021 - 11 - 01
4
2021 - 10 - 29
4
2021 - 10 - 07
3
2021 - 09 - 16
4
2021 - 09 - 03
3
2021 - 08 - 18
3
2021 - 08 - 11
3
2021 - 08 - 09
3
2021 - 07 - 29
3
2021 - 07 - 23
3
2021 - 07 - 08
4
2021 - 06 - 29
3
2021 - 06 - 11
4
2021 - 06 - 09
5
2021 - 06 - 04
5
2021 - 06 - 03
3
2021 - 05 - 24
4
2021 - 05 - 12
3
2021 - 05 - 10
3
2021 - 04 - 23
3
2021 - 04 - 07
4
2021 - 04 - 05
3
2021 - 04 - 02
3
Sector
Commercial services
7
Communications
10
Consumer durables
2
Consumer non-durables
11
Distribution services
2
Electronic technology
19
Energy minerals
4
Finance
15
Finance and insurance
3
Health care and social assistance
1
Health services
3
Health technology
908
Industrial services
4
Information
2
Manufacturing
112
Mining, quarrying, and oil and gas extraction
2
Miscellaneous
1
N/a
43
Non-energy minerals
3
Process industries
14
Producer manufacturing
15
Professional, scientific, and technical services
5
Retail trade
4
Technology services
14
Utilities
3
Tags
Abbvie
52
Active
13
Aesthetic
21
Alliances
18
America
36
Antibody
10
Application
14
Approval
36
Atopic dermatitis
10
Biomidwest
39
Bioscience
9
Biotech-beach
10
Business
9
Cancer
47
Cd20
11
Chmp
10
Clinical-trials-phase-iii
25
Collaboration
20
Conference
27
Contraceptive
9
Contract
11
Deadline
17
Dermatitis
13
Disease
60
Drug
66
Duobody
11
Earnings
21
Europe
15
Events
22
Expected
15
Eye
16
Fda
41
Financial
21
Financial results
12
Genetown
11
Global
87
Growing
22
Growth
151
Health
18
Leukemia
14
Market
311
Meeting
10
Migraine
22
N/a
679
Pharma
17
Phase 3
30
Positive
29
Reach
11
Report
78
Research
68
Results
75
Rinvoq
27
Risankizumab
14
Set
9
Skyrizi
16
Therapeutics
68
Therapy
38
Treatment
112
Trial
30
Ulcerative colitis
14
Entities
Abbott laboratories
51
Abbvie inc.
908
Adc therapeutics sa
9
Agios pharmaceuticals, inc.
12
Albemarle corporation
7
Alcon inc.
13
Alexion pharmaceuticals, inc.
17
Alkermes plc
8
Alnylam pharmaceuticals, inc.
11
Amgen inc.
137
Anika therapeutics inc.
9
Astellas pharma inc
36
Astrazeneca plc
78
Aveo pharmaceuticals, inc.
10
Bausch health companies inc.
55
Baxter international inc.
22
Becton, dickinson and company
7
Beigene, ltd.
11
Biocryst pharmaceuticals, inc.
13
Biogen inc.
31
Blueprint medicines corporation
11
Boston scientific corporation
7
Bristol-myers squibb company
74
Clovis oncology, inc.
10
Coherus biosciences, inc.
36
Csl ltd
8
Cti biopharma corp.
7
Eli lilly and company
94
Endo international plc
11
Epizyme, inc.
10
Exelixis, inc.
11
Genmab a/s
24
Gilead sciences, inc.
36
Glaxosmithkline plc
135
Illumina, inc.
11
Incyte corporation
16
Ironwood pharmaceuticals, inc.
12
Johnson & johnson
139
Karyopharm therapeutics inc.
12
Medtronic plc
18
Mylan n.v.
14
Neos therapeutics, inc.
13
Novartis ag
200
Novo nordisk a/s
12
Omeros corporation
13
Orange
8
Otonomy, inc.
13
Pfizer, inc.
36
Regeneron pharmaceuticals, inc.
20
Rigel pharmaceuticals, inc.
10
Sanofi
175
Takeda pharmaceutical company limited
25
Teva pharmaceutical industries limited
10
Teva pharmaceutical industries ltd
108
Thermo fisher scientific inc
27
Ucb s.a.
12
Verastem, inc.
10
Viatris inc.
61
Xeris pharmaceuticals, inc.
11
Y-mabs therapeutics, inc.
10
Symbols
AAPL
1091
ABB
1301
ABBV
908
ABLZF
1041
ABT
1543
AMGN
694
ARVL
3798
AZN
587
BDX
722
BMY
597
BNPQF
1628
BNPQY
1628
BNPZY
1627
CNY
2011
CSCO
808
DHR
724
ERIC
1459
EXTR
581
FNCTF
6070
GE
851
GLAXF
604
GOOG
1094
GOOGL
1094
GSK
824
HON
1612
HUBS
1290
IBM
604
INR
2014
INTC
874
JNJ
3972
LLY
1546
LTUM
869
LYV
717
MDT
1192
MLPY
2012
MMM
868
MS
3637
MS-PE
1440
MSFT
1126
NOK
824
NOKBF
884
NVO
566
NVS
1108
NVSEF
901
ORCL
1080
PCRFF
590
PCRFY
590
PFE
642
PHG
884
PPRUF
1004
PPRUY
1005
SAP
1397
SAPGF
1131
SNOW
705
SNY
3985
SNYNF
3040
TMO
1427
TOT
1591
URR
2010
VZ
1056
Exchanges
Amex
2
Lse
26
Nasdaq
535
Nyse
908
Tsx
12
Crawled Date
2023 - 11 - 01
4
2023 - 09 - 18
5
2023 - 07 - 27
6
2023 - 07 - 26
6
2023 - 05 - 19
5
2023 - 05 - 15
6
2023 - 04 - 13
5
2023 - 04 - 12
6
2023 - 04 - 11
5
2023 - 02 - 13
4
2023 - 01 - 24
5
2023 - 01 - 10
4
2022 - 12 - 15
4
2022 - 12 - 06
4
2022 - 11 - 23
4
2022 - 10 - 20
4
2022 - 09 - 27
4
2022 - 09 - 19
5
2022 - 08 - 17
4
2022 - 08 - 02
5
2022 - 06 - 17
5
2022 - 05 - 16
4
2022 - 04 - 28
7
2022 - 04 - 13
5
2022 - 04 - 12
4
2022 - 04 - 08
5
2022 - 03 - 16
4
2022 - 03 - 08
4
2022 - 03 - 01
4
2022 - 02 - 17
4
2022 - 01 - 05
3
2021 - 12 - 14
3
2021 - 12 - 13
3
2021 - 12 - 06
3
2021 - 11 - 15
3
2021 - 11 - 05
3
2021 - 11 - 04
3
2021 - 11 - 01
4
2021 - 10 - 29
4
2021 - 10 - 07
3
2021 - 09 - 16
4
2021 - 09 - 03
3
2021 - 08 - 18
3
2021 - 08 - 11
3
2021 - 08 - 09
3
2021 - 07 - 29
3
2021 - 07 - 27
3
2021 - 07 - 08
4
2021 - 06 - 29
3
2021 - 06 - 11
4
2021 - 06 - 09
5
2021 - 06 - 04
5
2021 - 06 - 03
3
2021 - 05 - 24
3
2021 - 05 - 12
3
2021 - 05 - 10
3
2021 - 04 - 23
3
2021 - 04 - 07
4
2021 - 04 - 05
3
2021 - 04 - 02
3
Crawled Time
00:00
34
00:20
5
01:00
27
01:10
1
02:00
20
03:00
20
04:00
17
04:20
7
05:00
9
06:00
17
07:00
24
08:00
21
08:20
1
09:00
19
10:00
15
10:10
1
10:51
1
11:00
39
12:00
54
12:15
10
12:20
15
12:30
3
12:34
1
13:00
51
13:07
3
13:13
1
13:15
10
13:17
1
13:20
12
13:27
1
13:30
14
13:50
1
14:00
50
14:03
1
14:04
1
14:07
1
14:12
1
14:15
7
14:20
10
14:30
11
15:00
46
15:11
1
15:15
7
15:20
10
15:30
9
15:49
1
16:00
46
16:20
7
17:00
34
17:37
1
17:43
1
18:00
30
18:04
1
18:31
2
19:00
29
20:00
41
20:20
6
21:00
26
22:00
32
23:00
34
Source
beamforall.com
1
investor.assemblybio.com
2
www.biospace.com
229
www.fda.gov
24
www.globenewswire.com
68
www.jupiterwellnessinc.com
1
www.prnewswire.com
582
www.vermillion.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Abbv
save search
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
Published:
2023-11-30
(Crawled : 15:30)
- biospace.com/
MS
|
News
3 d
|
$80.89
1.95%
0.05%
9.6M
|
Finance
|
0.65%
|
O:
0.28%
H:
0.9%
C:
0.72%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.81%
|
O:
-0.35%
H:
3.4%
C:
3.17%
IMGN
M
|
$29.32
82.57%
-0.75%
30M
|
Health Technology
|
81.82%
|
O:
81.82%
H:
0.0%
C:
0.0%
elahere
abbvie
cancer
tumor
acquire
therapy
AbbVie Announces Positive Topline Results from Phase 2 LUMINOSITY Trial Evaluating Telisotuzumab-Vedotin (Teliso-V) for Patients with Previously Treated Non-Small Cell Lung Cancer (NSCLC)
Published:
2023-11-29
(Crawled : 14:30)
- biospace.com/
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.42%
|
O:
-0.73%
H:
0.78%
C:
0.35%
lung
abbvie
positive
cancer
cell
topline
trial
results
CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023
Published:
2023-11-29
(Crawled : 12:00)
- prnewswire.com
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.42%
|
O:
-0.73%
H:
0.78%
C:
0.35%
CLGN
|
$5.35
-2.37%
1.68%
19K
|
Health Technology
|
-4.86%
|
O:
-3.82%
H:
4.15%
C:
-3.43%
biotechnologies
financial
results
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update
Published:
2023-11-28
(Crawled : 21:00)
- globenewswire.com
ALVO
|
$9.45
-0.53%
0.0%
180K
|
n/a
|
-4.04%
|
O:
0.0%
H:
0.0%
C:
-5.05%
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
3.36%
|
O:
-0.04%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.42%
|
O:
-0.73%
H:
0.78%
C:
0.35%
KMDA
|
$4.65
-1.69%
0.0%
9.6K
|
Health Technology
|
-1.15%
|
O:
0.73%
H:
0.0%
C:
-1.04%
business
update
financial
results
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides a Business Update
Published:
2023-11-28
(Crawled : 21:00)
- globenewswire.com
ALVO
|
$9.45
-0.53%
0.0%
180K
|
n/a
|
-4.04%
|
O:
0.0%
H:
0.0%
C:
-5.05%
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
3.36%
|
O:
-0.04%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.42%
|
O:
-0.73%
H:
0.78%
C:
0.35%
KMDA
|
$4.65
-1.69%
0.0%
9.6K
|
Health Technology
|
-1.15%
|
O:
0.73%
H:
0.0%
C:
-1.04%
business
update
financial
results
Open-Angle Glaucoma Therapeutics Market size to grow by USD 2.36 billion from 2022 to 2027, North America to account for 51% of market growth - Technavio
Published:
2023-11-28
(Crawled : 06:00)
- prnewswire.com
NVS
|
$98.13
0.24%
-0.16%
1.2M
|
Health Technology
|
-0.23%
|
O:
-0.74%
H:
0.08%
C:
-0.22%
BHC
|
$7.36
3.08%
0.0%
1.8M
|
Health Technology
|
5.86%
|
O:
1.48%
H:
1.17%
C:
0.29%
ALC
|
$75.85
0.29%
0.0%
970K
|
Health Technology
|
2.0%
|
O:
-0.75%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.62%
|
O:
0.19%
H:
0.0%
C:
0.0%
america
glaucoma
therapeutics
growth
market
AbbVie Announces U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) Updates for Epcoritamab (EPKINLY®/TEPKINLY®) for the Treatment of Relapsed/Refractory Follicular Lymphoma
Published:
2023-11-27
(Crawled : 12:00)
- prnewswire.com
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.35%
|
O:
-0.26%
H:
0.0%
C:
0.0%
epkinly
drug
abbvie
food
treatment
Global Pain Management Drugs and Devices Market Report 2023 - Focus on Key Players in Pain Management: Abbott Laboratories, AbbVie, Novartis and More
Published:
2023-11-24
(Crawled : 23:00)
- prnewswire.com
ABT
|
$104.88
0.57%
-0.01%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
management
report
global
novartis
market
HIV Drugs Market to Reach $51.1 Billion, Globally, by 2032 at 4.5% CAGR: Allied Market Research
Published:
2023-11-17
(Crawled : 16:00)
- prnewswire.com
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
4.67%
|
O:
0.78%
H:
0.0%
C:
0.0%
BMY
P
|
$50.1
1.46%
0.08%
13M
|
Health Technology
|
-2.87%
|
O:
0.67%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.97%
|
O:
0.01%
H:
0.0%
C:
0.0%
GILD
|
$77.65
1.37%
-0.05%
5.4M
|
Health Technology
|
2.08%
|
O:
-0.13%
H:
0.0%
C:
0.0%
reach
research
hiv
market
United States Employment Screening Market Insights Report 2023: A $2+ Billion Industry in 2022 - Forecasts to 2027 - Importance of Social Media Gaining Traction
Published:
2023-11-16
(Crawled : 03:00)
- prnewswire.com
AZNCF
|
$125.0
-2.72%
8.8%
3.4K
|
Health Technology
|
2.67%
|
O:
-2.16%
H:
4.44%
C:
2.2%
TFX
M
|
$227.67
0.88%
0.0%
220K
|
Health Technology
|
7.58%
|
O:
1.76%
H:
1.16%
C:
0.07%
GE
|
$122.5
0.58%
0.16%
4.5M
|
Electronic Technology
|
4.1%
|
O:
-0.35%
H:
2.03%
C:
2.02%
BDX
S
|
$238.25
0.88%
0.37%
1.5M
|
Health Technology
|
0.94%
|
O:
0.48%
H:
0.84%
C:
0.18%
BAX
|
$36.55
1.3%
-0.08%
4.2M
|
Health Technology
|
5.54%
|
O:
2.67%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
3.26%
|
O:
0.28%
H:
0.39%
C:
0.0%
ABT
|
$104.88
0.57%
-0.01%
4.7M
|
Health Technology
|
6.93%
|
O:
0.5%
H:
0.0%
C:
0.0%
MMM
|
$99.85
0.79%
0.04%
2.8M
|
Producer Manufacturing
|
2.96%
|
O:
0.25%
H:
0.0%
C:
0.0%
ICUI
|
$91.34
4.08%
0.0%
480K
|
Health Technology
|
1.22%
|
O:
1.25%
H:
0.0%
C:
0.0%
AZN
|
$64.79
0.31%
0.03%
3.6M
|
Health Technology
|
1.69%
|
O:
-0.22%
H:
0.71%
C:
0.6%
media
report
market
Precision Medicine Market size to grow by 54.7 billion from 2022 to 2027- Technavio
Published:
2023-11-14
(Crawled : 23:00)
- prnewswire.com
AZNCF
|
$125.0
-2.72%
8.8%
3.4K
|
Health Technology
|
3.01%
|
O:
0.52%
H:
1.79%
C:
-0.19%
NVSEF
|
$97.95
1.48%
2.98%
100
|
Health Technology
|
5.2%
|
O:
1.25%
H:
0.0%
C:
-0.32%
TMO
|
$496.13
0.08%
0.0%
1.2M
|
Health Technology
|
7.91%
|
O:
1.67%
H:
0.0%
C:
0.0%
NVS
|
$98.13
0.24%
-0.16%
1.2M
|
Health Technology
|
3.26%
|
O:
-0.26%
H:
0.37%
C:
-0.6%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.49%
|
O:
-0.74%
H:
0.0%
C:
0.0%
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
1.82%
|
O:
-0.72%
H:
0.0%
C:
0.0%
AZN
|
$64.79
0.31%
0.03%
3.6M
|
Health Technology
|
0.54%
|
O:
-1.14%
H:
0.0%
C:
0.0%
market
Opioid Market Forecast: In-depth Analysis Predicts Continued Growth to $25.3 Billion by 2030
Published:
2023-11-14
(Crawled : 02:00)
- prnewswire.com
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
6.15%
|
O:
0.17%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.98%
|
O:
0.47%
H:
0.0%
C:
0.0%
SNY
|
$46.72
-0.06%
0.06%
1.2M
|
Health Technology
|
2.51%
|
O:
0.68%
H:
0.0%
C:
0.0%
opioid
growth
market
Global Pharmaceutical Contract Manufacturing Market Report 2023-2030 with Competitive Analysis of Major Players - Overview, Financials, Product Portfolio, Key Developments, Business Strategy, SWOT
Published:
2023-11-14
(Crawled : 01:00)
- prnewswire.com
TMO
|
$496.13
0.08%
0.0%
1.2M
|
Health Technology
|
10.58%
|
O:
2.48%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.98%
|
O:
0.47%
H:
0.0%
C:
0.0%
report
business
contract
global
market
NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year
Published:
2023-11-13
(Crawled : 21:00)
- globenewswire.com
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
2.98%
|
O:
0.47%
H:
0.0%
C:
0.0%
revenue
Oncology Drugs Market worth $520 billion by 2033 - Exclusive Report by We Market Research
Published:
2023-11-10
(Crawled : 15:00)
- prnewswire.com
PFE
|
$28.91
-5.12%
0.0%
100M
|
Health Technology
|
-7.15%
|
O:
-4.83%
H:
0.0%
C:
0.0%
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
4.31%
|
O:
-1.24%
H:
0.0%
C:
0.0%
BMY
P
|
$50.1
1.46%
0.08%
13M
|
Health Technology
|
-5.89%
|
O:
-3.68%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
3.15%
|
O:
0.44%
H:
0.0%
C:
0.0%
AZN
|
$64.79
0.31%
0.03%
3.6M
|
Health Technology
|
-0.81%
|
O:
-2.88%
H:
0.0%
C:
0.0%
report
research
market
Mexico aesthetic devices market to grow by USD 533.06 million from 2023 to 2028- Technavio
Published:
2023-11-09
(Crawled : 23:00)
- prnewswire.com
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
3.15%
|
O:
0.44%
H:
0.0%
C:
0.0%
aesthetic
market
Trishula Therapeutics Initiates Phase 2 Trial of TTX-030, an Anti-CD39 Antibody, in First Line Metastatic Pancreatic Cancer Patients
Published:
2023-11-09
(Crawled : 14:00)
- biospace.com/
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
-0.84%
|
O:
-1.81%
H:
0.43%
C:
-2.1%
ttx-030
cancer
pancreatic
trial
therapeutics
Ironwood Pharmaceuticals Reports Third Quarter 2023 Results
Published:
2023-11-09
(Crawled : 13:30)
- biospace.com/
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
-0.84%
|
O:
-1.81%
H:
0.43%
C:
-2.1%
IRWD
|
$10.3
4.04%
1.46%
2.3M
|
Health Technology
|
5.69%
|
O:
2.04%
H:
4.37%
C:
0.21%
pharmaceuticals
ironwood
results
Advanced Anesthesia Devices and Ambulatory Surgical Centers Propel Growth in the US Anesthesia Market
Published:
2023-11-07
(Crawled : 00:00)
- prnewswire.com
AZNCF
|
$125.0
-2.72%
8.8%
3.4K
|
Health Technology
|
2.59%
|
O:
-1.99%
H:
1.92%
C:
1.89%
TFX
M
|
$227.67
0.88%
0.0%
220K
|
Health Technology
|
8.58%
|
O:
-2.14%
H:
0.0%
C:
0.0%
KKR
|
$74.87
-1.28%
-1.18%
5.2M
|
Finance
|
27.25%
|
O:
5.05%
H:
0.28%
C:
-0.32%
GE
|
$122.5
0.58%
0.16%
4.5M
|
Electronic Technology
|
9.28%
|
O:
0.66%
H:
1.65%
C:
1.47%
BDX
S
|
$238.25
0.88%
0.37%
1.5M
|
Health Technology
|
-9.07%
|
O:
-0.64%
H:
0.0%
C:
-0.64%
BAX
|
$36.55
1.3%
-0.08%
4.2M
|
Health Technology
|
5.66%
|
O:
0.03%
H:
0.0%
C:
-1.19%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
0.7%
|
O:
1.55%
H:
0.0%
C:
0.0%
ABT
|
$104.88
0.57%
-0.01%
4.7M
|
Health Technology
|
9.5%
|
O:
0.04%
H:
0.54%
C:
-0.5%
MMM
|
$99.85
0.79%
0.04%
2.8M
|
Producer Manufacturing
|
6.21%
|
O:
0.69%
H:
0.0%
C:
0.0%
ICUI
|
$91.34
4.08%
0.0%
480K
|
Health Technology
|
-11.32%
|
O:
-15.97%
H:
4.7%
C:
4.21%
AZN
|
$64.79
0.31%
0.03%
3.6M
|
Health Technology
|
1.29%
|
O:
-0.06%
H:
0.64%
C:
-0.38%
propel
growth
market
Genmab Announces Financial Results for the First Nine Months of 2023
Published:
2023-11-07
(Crawled : 16:00)
- globenewswire.com
GNMSF
|
$314.475
-1.42%
-0.25%
860
|
Health Technology
|
11.81%
|
O:
0.39%
H:
4.92%
C:
1.52%
NVS
|
$98.13
0.24%
-0.16%
1.2M
|
Health Technology
|
4.69%
|
O:
0.38%
H:
0.18%
C:
0.16%
JNJ
|
$158.38
2.41%
0.0%
10M
|
Health Technology
|
3.17%
|
O:
0.18%
H:
0.0%
C:
0.0%
ABBV
|
$143.41
0.72%
-0.11%
4.9M
|
Health Technology
|
0.42%
|
O:
-0.28%
H:
0.0%
C:
0.0%
GMAB
|
$31.97
1.14%
-0.02%
680K
|
Health Technology
|
9.57%
|
O:
0.28%
H:
0.0%
C:
0.0%
BNTX
|
$99.4
-1.01%
-1.29%
800K
|
Health Technology
|
0.7%
|
O:
-1.4%
H:
0.0%
C:
0.0%
financial
results
← Previous
1
2
3
4
5
6
7
8
9
…
45
46
Next →
Gainers vs Losers
77%
23%
Top 10 Gainers
ID
4
|
$0.077
-9.41%
25.97%
420K
|
Finance
MGLD
|
$1.03
7.77%
14K
|
Manufacturing
CZOO
|
$0.4316
-6.52%
6.7%
65K
|
AUMN
|
$0.562
0.34%
4.5%
360K
|
Non-Energy Minerals
KEY
|
$13.22
6.7%
0.68%
18M
|
Finance
EGO
|
$13.52
2.97%
0.59%
2.5M
|
Non-Energy Minerals
BHIL
|
$0.2077
3.08%
0.58%
950K
|
Agriculture, Forestry, Fishing ...
MRT
|
$0.7266
11.41%
0.47%
220K
|
Finance
PSO
|
$11.71
-1.18%
0.43%
390K
|
Consumer Services
ASAN
4
|
$22.46
6.9%
0.4%
1.9M
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.